<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
60687-264-25
</NDCCode>
<PackageDescription>
30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-264-25) > 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (60687-264-95)
</PackageDescription>
<NDC11Code>
60687-0264-25
</NDC11Code>
<ProductNDC>
60687-264
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Mesalamine
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Mesalamine
</NonProprietaryName>
<DosageFormName>
TABLET, DELAYED RELEASE
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20161118
</StartMarketingDate>
<EndMarketingDate>
20190228
</EndMarketingDate>
<MarketingCategoryName>
NDA AUTHORIZED GENERIC
</MarketingCategoryName>
<ApplicationNumber>
NDA021830
</ApplicationNumber>
<LabelerName>
American Health Packaging
</LabelerName>
<SubstanceName>
MESALAMINE
</SubstanceName>
<StrengthNumber>
800
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes>
Aminosalicylate [EPC],Aminosalicylic Acids [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2019-03-01
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
20161118
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20190228
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>